I am an Assistant Professor of Anaesthesia at Harvard Medical School and a Research Associate in the Department of Anesthesiology, Critical Care, and Pain Medicine at Boston Children’s Hospital (BCH), where I also serve as Associate Director of Laboratory Research in the Division of Cardiac Anesthesia. My career has been defined by the development of an independent, internationally visible research program focused on innate immune mechanisms in critical illness, with particular emphasis on neutrophil heterogeneity, integrin biology, and immune-mediated lung injury across sepsis, cardiopulmonary bypass, and perioperative inflammation. My research integrates mechanistic immunology with advanced single-cell transcriptomics, functional assays, and machine learning approaches, leveraging both pediatric patient samples and rigorously validated murine models. A central theme of my work is the identification of pathogenic neutrophil subsets and immune circuits that drive organ dysfunction, with the goal of enabling precision-targeted therapeutic strategies.
I am an Assistant Professor of Anaesthesia at Harvard Medical School and a Research Associate in the Department of Anesthesiology, Critical Care, and Pain Medicine at Boston Children’s Hospital (BCH), where I also serve as Associate Director of Laboratory Research in the Division of Cardiac Anesthesia. My career has been defined by the development of an independent, internationally visible research program focused on innate immune mechanisms in critical illness, with particular emphasis on neutrophil heterogeneity, integrin biology, and immune-mediated lung injury across sepsis, cardiopulmonary bypass, and perioperative inflammation. My research integrates mechanistic immunology with advanced single-cell transcriptomics, functional assays, and machine learning approaches, leveraging both pediatric patient samples and rigorously validated murine models. A central theme of my work is the identification of pathogenic neutrophil subsets and immune circuits that drive organ dysfunction, with the goal of enabling precision-targeted therapeutic strategies.